Among the companies with shares expected to actively trade in
Tuesday's session are Hillshire Brands Co. (HSH), InterDigital Inc.
(IDCC) and Krispy Kreme Doughnuts Inc. (KKD).
G-III Apparel Group Ltd. (GIII) said its fiscal first-quarter
earnings increased 15% as the company reported a notable jump in
sales. The licensed apparel maker's results outpaced its own
expectations, and it provided a rosier outlook for the current
quarter compared with analysts' estimates while also boosting its
view for the year. Shares rose 5.1% to $79.77 premarket.
Guidewire Software Inc.'s (GWRE) fiscal third-quarter loss
narrowed, even as the software vendor reported an uptick in
operating expenses that offset revenue growth. Shares edged up 1.6%
to $37.50 premarket.
Hillshire on Tuesday said it would hold separate talks with
Pilgrim's Pride Corp. (PPC) and Tyson Foods Inc. (TSN), who have
offered to buy the maker of Jimmy Dean sausage and Sara Lee
desserts. Pilgrim's Pride had raised its bid for Hillshire to $55 a
share, topping Tyson's $50 a share offer. Hillshire's shares jumped
8.8% to $58.30 premarket.
InterDigital said it has entered into a patent license agreement
with Samsung Electronics Co., which resolves all pending litigation
between the two companies. Shares rose 8.7% to $40.65
premarket.
Krispy Kreme said fiscal first-quarter profit rose 20%, but
severe weather hurt its results and the doughnut chain lowered its
earnings guidance for the year. Shares dropped 11% to $17
premarket.
Quiksilver Inc. (ZQK) said its fiscal second-quarter loss
widened as the sport outfitter's sales declined across its brands.
Shares dropped 41% to $3.42 premarket.
Skyworks Solutions Inc. (SWKS) boosted its fiscal third-quarter
outlook as the wireless-chip supplier said it is benefiting from
the growth of connecting everyday objects to the Internet, known as
the Internet of Things. Shares rose 4.5% to $45.02 premarket.
Watch List:
Acadia Healthcare Co. Inc. (ACHC) agreed to acquire U.K.-based
independent behavioral-health services firm Partnerships in Care
for roughly $660 million, providing a foothold in Britain.
AT&T Inc. (T) again raised its revenue guidance for the
year, pointing to strong wireless trends in its second quarter. The
telecommunications giant said it expects to report that it added
more than 800,000 customers who signed long-term service contracts
in the period, up sharply from 551,000 a year earlier.
Li & Fung will distribute some of Coty Inc.'s (COTY) key
brands in China, including adidas, Rimmel and Playboy, as part of
an agreement between the two companies. The move is part of Coty's
efforts to reorganize its business in China and focus on growing
its business in the world's second largest economy, the company
said in a statement Tuesday.
Starboard Value LP, a New York investment adviser that has a
roughly 6% stake in Darden Restaurants Inc. (DRI), has formally
withdrawn its request for a special meeting of the board, but the
group remains steadfast in replacing the restaurant chain's board
of directors over the sale of the Red Lobster chain.
Dollar General Corp. (DG) said its fiscal first-quarter profit
edged up 1.1% as the discount retailer recorded higher overall
sales, though sales at existing stores missed the company's
expectations.
Equipment-finance company Element Financial Corp. (EFN.T) has
agreed to buy PHH Arval, the North American fleet-management unit
of PHH Corp. (PHH), for about $1.4 billion.
HealthSouth Corp. (HLS) said it expects to exceed its earnings
projections after it increased its ownership interest in Fairlawn
Rehabilitation Hospital, in Worcester, Mass.
J.M. Smucker Co. (SJM) said it raised the prices on most of its
coffee products by an average of 9% to reflect higher green coffee
costs. The price increases primarily affect Folgers and Dunkin
Donuts brand products and exclude products made for single-serve
coffee machines.
Norwegian vaccine company Vaccibody and Phibro Animal Health
Corp. (PAHC) have signed an exclusive license agreement for Phibro
to use Vaccibody's technology platform in developing vaccines for
the poultry market.
Teva Pharmaceutical Industries Ltd. (TEVA) has agreed to acquire
migraine treatment-focused biotechnology company Labrys Biologics
Inc. in a deal worth up to $825 million, as the drug maker looks to
broaden its pain care offerings.
Write to Maria Armental at maria.armental@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires